Pulmonary Hypertension Trial, Recruiting (NCT07337850)

Pulmonary Hypertension Trial, Recruiting NCT07337850 Sponsor: Tata Memorial Centre Condition: Pulmonary Hypertension

Printed from Voxsanity (voxsanity.com.au) — NCT07337850 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Pulmonary Hypertension

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are suspected to have a biliary tract cancer, specifically a type affecting the liver (called iHCC) or the gallbladder (called GBC)
You are male or female and aged 18 years or older
Your cancer is suspected to be at an advanced stage, meaning it may have spread to nearby tissues, lymph nodes, or blood vessels (confirm with trial site)
You have a type of gallbladder cancer (iGBC) that is either remaining after previous treatment or has spread to nearby lymph nodes
Your cancer is suspected to have come back after previous treatment, either based on blood test results or scan findings

Who may not be able to join:

You have decided to withdraw your agreement to take part in the trial (informed consent)
You currently have another separate cancer at the same time as the one being studied

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Dr.Shraddha Patkar, Tata Memorial Hospital

Phone: +91 9820074818

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07337850

Sponsor: Tata Memorial Centre

Phase: Not Applicable

Status: Recruiting

Condition: Pulmonary Hypertension

Trial contact: +91 9820074818

More information: https://clinicaltrials.gov/study/NCT07337850

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are suspected to have a biliary tract cancer, specifically a type affecting the liver (called iHCC) or the gallbladder (called GBC)
You are male or female and aged 18 years or older
Your cancer is suspected to be at an advanced stage, meaning it may have spread to nearby tissues, lymph nodes, or blood vessels (confirm with trial site)
You have a type of gallbladder cancer (iGBC) that is either remaining after previous treatment or has spread to nearby lymph nodes
Your cancer is suspected to have come back after previous treatment, either based on blood test results or scan findings

Who may not be able to join:

You have decided to withdraw your agreement to take part in the trial (informed consent)
You currently have another separate cancer at the same time as the one being studied

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Tata Memorial Centre

Registry

ClinicalTrials.gov

Start date

25 September 2024

Est. completion

1 March 2026

Where this trial is recruiting

🇮🇳 India

Primary endpoints

Diagnostic accuracy of Ga-68 FAPI PET/CT for detection of metastatic or recurrent disease (measured as sensitivity and specificity)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov